LDHA

L-lactate dehydrogenase A chain · P00338 · LDHA on Sugi Atlas →

65,341 patent compounds predicted against LDHA, 44,136 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL92986 SCHEMBL92986 0.48 11/20
SCHEMBL7624 SCHEMBL7624 1.00 8/20
SCHEMBL8027 SCHEMBL8027 1.00 7/20
SCHEMBL8347 SCHEMBL8347 0.66 7/20
SCHEMBL8240 SCHEMBL8240 0.58 7/20
SCHEMBL8014 SCHEMBL8014 0.55 7/20
Pki-166 Pki-166 (SCHEMBL173524) 0.44 7/20
Pki-166 Pki-166 (SCHEMBL177814) 0.44 7/20
SCHEMBL7300 SCHEMBL7300 1.00 6/20
SCHEMBL7814 SCHEMBL7814 1.00 6/20
SCHEMBL8149 SCHEMBL8149 0.79 6/20
SCHEMBL7988 SCHEMBL7988 0.70 6/20
SCHEMBL8015 SCHEMBL8015 0.69 6/20
SCHEMBL7731 SCHEMBL7731 0.67 6/20
SCHEMBL7705 SCHEMBL7705 0.61 6/20
SCHEMBL8154 SCHEMBL8154 0.56 6/20
SCHEMBL13308 SCHEMBL13308 1.00 5/20
SCHEMBL7923 SCHEMBL7923 0.84 5/20
SCHEMBL7108 SCHEMBL7108 0.82 5/20
SCHEMBL12031 SCHEMBL12031 0.80 5/20

Clinical trials — most relevant to LDHA by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy PHASE4NOT_YET_RECRUITING
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients PHASE4NOT_YET_RECRUITING
Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593) PHASE4COMPLETED
Early Lactate-Directed Therapy in the Intensive Care Unit (ICU) PHASE3COMPLETED
First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer PHASE2COMPLETED
Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors PHASE2ACTIVE_NOT_RECRUITING
Study to Evaluate the Efficacy and Safety of REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) PHASE2COMPLETED
Acetylcarnitine and Insulin Sensitivity PHASE2COMPLETED
Efficacy and Safety of the Treatment of Pyruvate Dehydrogenase Deficiency Patients With Glycerol Phenylbutyrate (RAVICTI) PHASE2RECRUITING
Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury EARLY_PHASE1NOT_YET_RECRUITING
Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma nanUNKNOWN
Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS nanRECRUITING
Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University Hospital nanUNKNOWN
Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study nanCOMPLETED
Evaluation of Lactate Dehydrogenase as Decision Support for Admissions to Neonatal Ward nanCOMPLETED
COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU nanCOMPLETED
Correlation Between Inferior Vena Cava Collapsibility Index and Serum Lactate in Poly-trauma Patients nanNOT_YET_RECRUITING
Potential Synergistic Effect of Combined Blood Flow Restriction Training and Betaine Supplementation on Skeletal Muscle nanCOMPLETED
Safety of D-lactate Producing Probiotics nanCOMPLETED
Effect of PNF and Lumbar Stabilization Exercises on Muscle Strength and Endurance in Lumbar Disc Hernia nanCOMPLETED
The Effectiveness of Surgical Treatment of Patients With Ischemic Cardiomyopathy nanCOMPLETED
Single Effort in Air Temperature of Minus 10°C nanCOMPLETED
13C Pyruvate DNP MR Spectroscopy for Lymphoma Treatment Response Assessment nanUNKNOWN
Study of CRP, Ferritine and D-Dimer in Covid-19 Patients Admitted To Respiratory ICU in Assuit University Hospitals nanUNKNOWN
Evaluation of a PCM Mattress to Treat HIE Infants During Transport nanUNKNOWN
Infrared Low-level Laser Therapy Before Intense Progressive Running Test of High-level Soccer Players nanCOMPLETED
Early Lactate Clearance Rate in Sepsis nanUNKNOWN
Artemisinin Resistance In Malaria Treated With IV Artesunate nanWITHDRAWN
Effects of Protein Hydrolysate Supplementation Influencing Strength Recovery and Expression of Muscle Damage Markers Post-exercise nanCOMPLETED
Biologic Mechanisms for Pain Variation After Physical Activity in Osteoarthritis nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a LDHA binder may also engage these)

ProteinNameSimilarity
A0A1F3 1.000 A0A1F3 →
Q9BE24 1.000 Q9BE24 →
P19858 1.000 P19858 →
Q9XT87 1.000 Q9XT87 →
Q5R5F0 1.000 Q5R5F0 →
Q9PW06 1.000 Q9PW06 →
P04642 1.000 P04642 →
Q98SL0 1.000 Q98SL0 →
Q5R1W9 1.000 Q5R1W9 →
Q9PT43 1.000 Q9PT43 →
Q9PT42 1.000 Q9PT42 →
P00337 1.000 P00337 →
P16125 1.000 P16125 →
Q9YGL2 1.000 Q9YGL2 →
Q5E9B1 1.000 Q5E9B1 →
P69082 1.000 P69082 →
O13277 0.999 O13277 →
Q9PW07 0.999 Q9PW07 →
Q1EG91 0.999 Q1EG91 →
P00336 0.998 P00336 →
O93541 0.998 O93541 →
P06151 0.998 P06151 →
P00339 0.997 P00339 →
P79913 0.997 P79913 →
P00341 0.997 P00341 →
Q9W7L5 0.997 Q9W7L5 →
P13491 0.997 P13491 →
P13743 0.997 P13743 →
P79912 0.997 P79912 →
P42123 0.996 P42123 →